
enVVeno Medical Corporation (NVNO)
NVNO Stock Price Chart
Explore enVVeno Medical Corporation interactive price chart. Choose custom timeframes to analyze NVNO price movements and trends.
NVNO Company Profile
Discover essential business fundamentals and corporate details for enVVeno Medical Corporation (NVNO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
31 May 2018
Employees
37.00
Website
https://www.envveno.comCEO
Robert A. Berman
Description
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
NVNO Financial Timeline
Browse a chronological timeline of enVVeno Medical Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 26 Feb 2026
Upcoming earnings on 29 Oct 2025
Earnings released on 31 Jul 2025
EPS came in at -$0.33 falling short of the estimated -$0.30 by -10.00%.
Earnings released on 30 Apr 2025
EPS came in at -$0.22 surpassing the estimated -$0.34 by +35.29%.
Earnings released on 27 Feb 2025
EPS came in at -$0.30 surpassing the estimated -$0.35 by +14.29%, while revenue for the quarter reached $812.00K .
Earnings released on 30 Oct 2024
EPS came in at -$0.35 falling short of the estimated -$0.33 by -6.06%.
Earnings released on 31 Jul 2024
EPS came in at -$0.31 surpassing the estimated -$0.36 by +13.89%.
Earnings released on 8 May 2024
EPS came in at -$0.31 surpassing the estimated -$0.40 by +22.50%.
Earnings released on 29 Feb 2024
EPS came in at -$0.32 surpassing the estimated -$0.46 by +30.43%, while revenue for the quarter reached $824.00K .
Earnings released on 26 Oct 2023
EPS came in at -$0.45 surpassing the estimated -$0.48 by +6.25%.
Earnings released on 31 Jul 2023
EPS came in at -$0.58 falling short of the estimated -$0.49 by -18.37%.
Earnings released on 1 May 2023
EPS came in at -$0.57 falling short of the estimated $0.48 by -218.75%.
Earnings released on 2 Mar 2023
EPS came in at -$0.55 surpassing the estimated -$0.57 by +3.51%.
Earnings released on 27 Oct 2022
EPS came in at -$0.54 falling short of the estimated -$0.52 by -3.85%.
Earnings released on 3 Aug 2022
EPS came in at -$0.63 falling short of the estimated -$0.33 by -90.91%.
Earnings released on 29 Apr 2022
EPS came in at -$0.47 falling short of the estimated -$0.29 by -62.07%.
Earnings released on 28 Mar 2022
EPS came in at -$0.94 falling short of the estimated -$0.33 by -184.85%.
Earnings released on 12 Nov 2021
EPS came in at -$0.26 surpassing the estimated -$0.34 by +23.53%.
Earnings released on 11 Aug 2021
EPS came in at -$0.28 surpassing the estimated -$0.34 by +17.65%.
Earnings released on 12 May 2021
EPS came in at -$0.48 falling short of the estimated -$0.34 by -41.18%.
Earnings released on 31 Mar 2021
EPS came in at -$2.46 falling short of the estimated -$0.98 by -151.02%, while revenue for the quarter reached $31.24K .
Stock split effective on 30 Nov 2020
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 Nov 2020
EPS came in at -$1.25 matching the estimated -$1.25.
NVNO Stock Performance
Access detailed NVNO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.